HC-5404-FU

N/A

Report date: 2024/01/29 15:08:52
NME

Base Information

Drug NameHC-5404-FU
Drug Alias NamePERK inhibitor (HiberCell)HC-5404-FUHC-5404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitors
TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursSmall Cell Lung Carcinoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHiberCell Inc
China Registration ClassN/A

Develop Information

Active CompaniesAveo Pharmaceuticals IncHiberCell Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursSmall Cell Lung Carcinoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A